---
clients:
- BioNTech
- AWS
date: 2023-11-30
description: BioNTech, a biotechnology company focusing on individualized cancer medicine,
  needed to migrate to the cloud and build a cloud center of excellence. This was
  an essential part of their growth strategy and helped manage their compliance and
  GxP qualification needs. GxP ensures that regulated organizations comply with specific
  and secure manufacturing and storage processes and procedures. In this session,
  hear about the challenges and lessons learned when achieving continuous compliance.
  Also, dis
event: unknown
has_transcript: true
language: en-US
playlist: ''
tags:
- compliance
- cloud-migration
- aws
- biotech
- gxp
- security
- devops
thematic: media
title: AWS re:Invent 2023 - How to optimize continuous compliance processes in your
  deployments (SEC101)
url: https://www.youtube.com/watch?v=jpJ7H9ohPFg
video_id: jpJ7H9ohPFg
year: 2023
---

# AWS re:Invent 2023 - How to optimize continuous compliance processes in your deployments (SEC101)

> [!info] Video
> 📺 [Watch on YouTube](https://www.youtube.com/watch?v=jpJ7H9ohPFg)
> 📅 2023-11-30 | 🎤 unknown | 🌐 en-US
> 🏢 Clients: [[BioNTech]] [[AWS]]

# Optimizing Continuous Compliance in Cloud Deployments

## Overview of the Session

At AWS re:Invent 2023, BioNTech, in partnership with Lacework, presented session SEC101 on how to optimize continuous compliance processes within cloud deployments. BioNTech, a biotechnology company best known for its pioneering work in individualized cancer medicine and mRNA-based therapeutics, shared how its rapid growth created an urgent need to migrate workloads to the cloud and establish a Cloud Center of Excellence. The discussion centered on how the company reconciled the speed and flexibility of cloud-native development with the stringent regulatory requirements that govern life sciences organizations.

## Compliance Challenges in a Regulated Environment

### GxP Requirements and Cloud Adoption

A central theme of the session was GxP compliance, the umbrella set of "Good Practice" guidelines that regulators impose on pharmaceutical and biotech companies to guarantee the safety, integrity, and traceability of manufacturing and data storage processes. For BioNTech, every system that touches research, manufacturing, or patient-facing data must be formally qualified, documented, and auditable. Translating these traditionally slow, paper-driven qualification practices into a fast-moving cloud environment posed significant cultural and technical challenges. The team described how legacy qualification processes could take up to two months per use case, creating a bottleneck that conflicted with the agility expected from cloud platforms and threatened the business value of cloud migration itself.

### Building a Cloud Center of Excellence

To address these tensions, BioNTech invested in a Cloud Center of Excellence that brought together cloud architects, security engineers, and quality and compliance specialists under a unified governance model. This cross-functional team established standardized guardrails, reusable patterns, and shared services so that individual product teams could innovate quickly without each having to reinvent compliance controls. The Center of Excellence also served as the bridge between regulatory expectations and engineering practice, ensuring that controls were both technically enforceable and acceptable to auditors.

## Automating Continuous Compliance

### Infrastructure as Code as the Foundation

The cornerstone of BioNTech's solution was a shift to Infrastructure as Code, which allowed every cloud resource to be defined, versioned, and deployed in a repeatable and auditable way. By treating infrastructure definitions as the single source of truth, the team could automatically generate qualification evidence from the same artifacts used to deploy environments. This approach eliminated the gap between what was documented and what was actually running, a frequent source of audit findings in regulated industries.

### A New Automatic Qualification System

Building on this foundation, BioNTech developed an automatic qualification system that drastically compressed compliance timelines. Where prior manual qualification of a new use case required roughly two months of effort, the new system reduced that to approximately two minutes. The platform validates infrastructure templates against predefined controls, executes automated tests, and produces the qualification documentation needed to satisfy GxP auditors as part of the deployment pipeline itself. Continuous monitoring and posture management capabilities, supported by Lacework as an AWS Partner, complement the deployment-time checks by detecting drift and anomalous activity throughout the lifecycle of each workload.

### Lessons Learned and Outcomes

The speakers emphasized several lessons drawn from this transformation. Engaging quality and regulatory stakeholders early was essential to build trust in automated evidence and to retire manual review steps. Standardization through reusable, pre-qualified building blocks proved more impactful than attempting to certify each project individually. Finally, embedding compliance into the same tooling that developers already use turned regulatory adherence from a barrier into an enabler of speed. The outcome for BioNTech is a continuously compliant cloud environment that supports faster delivery of innovative therapies while preserving the rigor demanded by life sciences regulators.

## Key Takeaways

The session demonstrated that continuous compliance is achievable even in highly regulated industries when organizations combine a strong governance model, Infrastructure as Code, and automated qualification tooling. BioNTech's experience shows that compliance need not slow cloud adoption; with the right architecture and partnerships, it can be accelerated by orders of magnitude, freeing engineering teams to focus on the science that ultimately benefits patients.